The research study provides an in-depth analysis of the Global Gene Therapy Market, covering aspects such as industry size and share, market classification, competition by manufacturers, market drivers and restraints, market trends, market sales and revenue, and market forecast.
PORTLAND, Oregon, Feb. 13, 2019 /PRNewswire/ -- Big Market Research added a report, "Gene Therapy Market By Vector Type (Viral Vector And Non-Viral Vector), Gene Type (Antigen, Cytokine, Tumor Suppressor, Suicide, Deficiency, Growth Factors, Receptors, And Others), And Applications (Oncological Disorders, Rare Diseases, Cardiovascular Diseases, Neurological Disorders, Infectious Disease, And Other Diseases) - Global Opportunity Analysis And Industry Forecast, 2017-2023" According to the report, the gene therapy market garnered $584 million in 2016, and is likely to accrue a sum of $4,402 million by 2023, registering a CAGR of 33.3% from 2017 to 2023.
The information provided in the Global Gene Therapy Market Report is a result of an extensive primary and secondary research activities. The report serves as useful tool for market players, investors, industry experts, and other individuals interested about the market. It helps them get readily available information to understand the current and future market trends and opportunities.
Get a Sample Copy of this Premium Research Report: https://www.bigmarketresearch.com/request-sample/2449055
The key findings of the report are discussed. It includes the top investment pockets, top winning strategies, top player positioning, Porter's five forces analysis, and market dynamics including the drivers, restraints, and opportunities.
The report provides an analysis of the drivers, restraints, and opportunities of the gene therapy market. Factors such as high investment for R&D activities pertaining to gene therapy, increase in prevalence of cancer, and growing awareness regarding gene therapy. However, high cost associated with gene therapies and unwanted immune responses impede the growth of the market. On the other hand, untapped potential for emerging markets provides lucrative opportunities for the growth of the market.
The global gene therapy market report segments the market based on type, gene type, applications, and geography. Based on type, the market is divided into viral vector and non-viral vector. Based on gene type, the market is divided into antigen, cytokine, tumor suppressor, suicide, deficiency, growth factors, receptors, and others. Based on applications, the market is classified into oncological disorders, rare diseases, cardiovascular diseases, neurological disorders, infectious disease, and other diseases. Geographically, the market analysis has been done for the regions such as North America, Europe, Asia-Pacific, and LAMEA. The segments of the market are studied on the basis of the key market trends, key growth factors and opportunities, market size and forecast, and market analyses by country.
Inquiry before Purchase of this Report: https://www.bigmarketresearch.com/purchase-enquiry/2449055
Among vector types, viral vectors accounted for the highest share in 2016 and is likely to maintain its dominance during the forecast period. Non-viral vector is expected to be lucrative, owing to various technological advancements in these vectors. Among gene types, the antigen segment was the lead revenue generator in 2016, accounting for two-ninths of the total share. Among applications, the oncological disorders segment is the largest contributor towards the market growth. North America held the highest share in 2016, owing to the high prevalence of cancer in the region, high disposable income of consumers, and high funding for R&D activities associated with gene therapy in the region. However, Asia-Pacific is likely to grow at the fastest CAGR during the study period. This is because of the rise in incidence of cancer, increase in government initiatives to improve healthcare infrastructure, and rise in healthcare expenditure.
Top Companies in Global Gene Therapy Market:
The report offers an analysis of the prominent players operating in the global gene therapy market. Besides their basic information, the study offers details about their product portfolio, company snapshot, operating business segments, business performance, and key strategic moves and developments. The key players included in the study are Adaptimmune Therapeutics Plc., Biocancell Ltd., Bluebird Bio, Inc., Celgene Corporation, Gilead Sciences, Inc., Glaxosmithkline Plc., Merck & Co., Inc., Novartis AG, Oncogenex Pharmaceuticals, Inc., and Spark Therapeutics, Inc.
Related Reports from the Industry Vertical:
DNA Sequencing Market by Product, Application, Technology, and End User: Global Opportunity Analysis and Industry Forecast, 2017 – 2025
The global DNA sequencing market was valued at $6,243 million in 2017, and is expected to reach $25,470 million in 2025, registering a CAGR of 19.0% from 2018 to 2025. DNA sequencing encompasses both Sanger's method of sequencing and non-Sanger's methods of sequencing. Different advantages associated with DNA sequencing include low cost, high accuracy & speed, and precise results even from low sample input over microarray and other genomic analysis methods.
Read More at: https://www.bigmarketresearch.com/dna-sequencing-market
Cancer Therapeutics Market by Top Selling Drugs and By Application: Global Opportunity Analysis and Industry Forecast, 2017 – 2023
Cancer has become extensively prevalent worldwide which in turn has led to rise in demand of cancer therapeutics. The global cancer therapeutics market was valued at $81,291 million in 2016 and is estimated to reach at $178,863 million by 2023, registering a CAGR of 11.9% from 2017 to 2023.
Big Market Research has a range of research reports from various publishers across the world. Our database of reports of various market categories and sub-categories would help to find the exact report you may be looking for.
We are instrumental in providing quantitative and qualitative insights on your area of interest by bringing reports from various publishers at one place to save your time and money. A lot of organizations across the world are gaining profits and great benefits from information gained through reports sourced by us.
5933 NE Win Sivers Drive, #205, Portland,
OR 97220 United States
Toll Free: +1-800-910-6452
SOURCE Big Market Research